AAAAAA

   
Results: 1-15 |
Results: 15
CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS
Authors: FAUCHER C FORTANIER C LECORROLLER AG CHABANNON C MAQUARTMOULIN G NOVAKOVITCH G CHABBERT I SCHULLER MP MARANINCHI D MOATTI JP BLAISE D
Citation: C. Faucher et al., CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 1-1
CLINICAL AND ECONOMIC COMPARISON OF LENOGRASTIM-PRIMED BLOOD-CELLS (BC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION
Authors: FAUCHER C FORTANIER C VIENS P LECORROLLER AG CHABANNON C CAMERLO J NOVAKOVITCH G GASTAUT JA MARANINCHI D MOATTI JP BLAISE D
Citation: C. Faucher et al., CLINICAL AND ECONOMIC COMPARISON OF LENOGRASTIM-PRIMED BLOOD-CELLS (BC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION, Bone marrow transplantation, 21, 1998, pp. 92-98
IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT
Authors: BLAISE D JOURDAN E FEGUEUX N MICHALLET M REIFFERS J JOUET JP MICHEL G FAUCHER C FORTANIER C SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT, Bone marrow transplantation, 21, 1998, pp. 103-103
IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION OVER THE AGE OF 45
Authors: BLAISE D JOURDAN E FEGUEUX N MICHALLET M REIFFERS J JOUET JP FAUCHER C FORTANIER C SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION OVER THE AGE OF 45, Bone marrow transplantation, 21, 1998, pp. 103-103
CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS
Authors: FAUCHER C FORTANIER C LECORROLLER AG CHABANNON C MAQUARTMOULIN G NOVAKOVITCH G CHABBERT I SCHULLER MP MARANINCHI D MOATTI JP BLAISE D
Citation: C. Faucher et al., CLINICAL ECONOMIC AND QUALITY-OF-LIFE ASSESSMENT OF LENOGRASTIM PRIMING AND PERIPHERAL-BLOOD PROGENITOR CELLS (PBSC) HARVESTING FOR 31 HEALTHY DONORS, Bone marrow transplantation, 21, 1998, pp. 146-146
IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT
Authors: BLAISE D JOURDAN E FEGUEUX N MICHALLET M REIFFERS J JOUET JP MICHEL G FAUCHER C FORTANIER C SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., IMPACT OF ALLOGENEIC PBSC TRANSPLANTATION IN A POPULATION OF STANDARDRISK PATIENT, Bone marrow transplantation, 21, 1998, pp. 147-147
AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULTS AND CHILDREN WITH NONLEUKEMIC MALIGNANT DISEASE - A RANDOMIZED ECONOMIC-STUDY
Authors: LECORROLLER AG FAUCHER C AUPERIN A BLAISE D FORTANIER C BENHAMOU E HARTMANN O BROSSE JC MARANINCHI D MOATTI JP
Citation: Ag. Lecorroller et al., AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULTS AND CHILDREN WITH NONLEUKEMIC MALIGNANT DISEASE - A RANDOMIZED ECONOMIC-STUDY, PharmacoEconomics, 11(5), 1997, pp. 454-463
AN EARLY ECONOMIC-EVALUATION OF A THERAPEUTIC INNOVATION IN THE FIELDOF CANCEROLOGY - THE CASE OF THE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ALLOGENEIC TRANSPLANTATION
Authors: FORTANIER C FAUCHER C TONNAIRE G PROTIERE C LECOROLLIER AG BLAISE D MOATTI JP
Citation: C. Fortanier et al., AN EARLY ECONOMIC-EVALUATION OF A THERAPEUTIC INNOVATION IN THE FIELDOF CANCEROLOGY - THE CASE OF THE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) ALLOGENEIC TRANSPLANTATION, European journal of cancer, 33, 1997, pp. 23-23
CELL THERAPY - A LEGISLATION TO INNOVATE
Authors: FORTANIER C MOATTI JP MARANINCHI D
Citation: C. Fortanier et al., CELL THERAPY - A LEGISLATION TO INNOVATE, MS. Medecine sciences, 13(3), 1997, pp. 360-363
LENOGRASTIM AS A PRIMING AGENT FOR ALLOGENEIC STEM-CELL TRANSPLANTATION
Authors: BLAISE D JOURDAN E FEGUEUX N MICHALLET M REIFFERS J JOUET JP MICHEL G FAUCHER C FORTANIER C HUA A SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., LENOGRASTIM AS A PRIMING AGENT FOR ALLOGENEIC STEM-CELL TRANSPLANTATION, Experimental hematology, 25(8), 1997, pp. 325-325
BONE-MARROW TRANSPLANTATION TO CELL THERA PIES - NEW FORMS OF COOPERATION BETWEEN MEDICINE AND INDUSTRIAL FIRMS
Authors: FORTANIER C MANNONICHAINE G MOATTI JP
Citation: C. Fortanier et al., BONE-MARROW TRANSPLANTATION TO CELL THERA PIES - NEW FORMS OF COOPERATION BETWEEN MEDICINE AND INDUSTRIAL FIRMS, Sciences sociales et sante, 15(2), 1997, pp. 7-34
ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION AFTER PRIMING WITH LENOGRASTIM - A PILOT-STUDY
Authors: BLAISE D JOURDAN E REIFFERS J MICHALLET M JOUET JP MICHEL G FAUCHER C FORTANIER C SCHULLER MP CHABANNON C MARANINCHI D
Citation: D. Blaise et al., ALLOGENEIC BLOOD STEM-CELL TRANSPLANTATION AFTER PRIMING WITH LENOGRASTIM - A PILOT-STUDY, Experimental hematology, 24(9), 1996, pp. 668-668
INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED PERIPHERAL-BLOOD CELLSUPPORT FOR UNTREATED POOR-PROGNOSIS LYMPHOMAS
Authors: STOPPA AM BOUABDALLAH R CHABANNON C NOVAKOVITCH G VEY N BOULET JM CAMERLO J FORTANIER C BLAISE D GASTAUT JA MARANINCHI D
Citation: Am. Stoppa et al., INTENSIVE SEQUENTIAL CHEMOTHERAPY WITH REPEATED PERIPHERAL-BLOOD CELLSUPPORT FOR UNTREATED POOR-PROGNOSIS LYMPHOMAS, Experimental hematology, 24(9), 1996, pp. 699-699
A PILOT-STUDY OF ALLOGENIC STEM-CELL TRANSPLANTATION AFTER PRIMING WITH LENOGRASTIM
Authors: BLAISE D ROSSI JF JOURDAN E MICHALLET M REIFFERS J JOUET JP MICHEL G FAUCHER C FORTANIER C HUA A SCHULLER MP BADRI N CHABANNON C MARANINCHI D
Citation: D. Blaise et al., A PILOT-STUDY OF ALLOGENIC STEM-CELL TRANSPLANTATION AFTER PRIMING WITH LENOGRASTIM, Blood, 88(10), 1996, pp. 2456-2456
COMPARISON OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION CLINICAL AND COST-EFFECTIVENESS STUDY
Authors: FAUCHER C FORTANIER C PROTIERE C TONNAIRE G CHABANNON C LECORROLLER AG CHARBONNIER A BANCILLON A BRADI N NOVAKOVITCH G MOATTI JP MARANINCHI D BLAISE D
Citation: C. Faucher et al., COMPARISON OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) AND BONE-MARROW (BM) ALLOGENEIC TRANSPLANTATION CLINICAL AND COST-EFFECTIVENESS STUDY, Blood, 86(10), 1995, pp. 1528-1528
Risultati: 1-15 |